Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELTX
#3598
Elicio Therapeutics, Inc. Common Stock
11.730
0
USD
+8.21%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+8.21%
Mudança mensal
-4.56%
Mudança em 6 meses
+17.30%
Mudança anual
+17.30%
Fechamento anterior
10.840
0
Abrir
11.730
0
Bid
Ask
Mínimo
11.730
0
High
11.730
0
Volume
8
Mercados
Ações
Cuidados de saúde
ELTX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
29.96 M
30.11 M
10.24 M
15.95 M
18.4 M
—
Valuation ratios
Enterprise value
—
—
47.8 M
83.78 M
137.28 M
511.29 M
Price to earnings ratio
—
—
-0.85
-1.2
-3.09
-9.99
Price to sales ratio
—
—
42.59
404.13
—
—
Price to cash flow ratio
—
—
-0.92
-1.68
-3.3
-12.48
Price to book ratio
—
—
2.64
-5.5
74.5
171.83
Enterprise value to EBITDA ratio
—
—
-1.38
-2.02
-3.85
-12.88
Profitability ratios
Return on assets %
-0.57
-0.74
-1.3
-1.84
-1.53
-1.41
Return on equity %
-0.67
-0.89
-3.09
4.59
-24.19
-14.38
Return on invested capital %
-1 812.01
-2 848.68
-1 919.58
-1 637.27
-1 764.5
-1 819.66
Gross margin %
98.47
100
100
100
—
—
Operating margin %
-138.84
-1 721.9
-5 077.41
-29.21 K
—
—
EBITDA margin %
-131.86
-1 714.17
-4 923.15
-28.85 K
—
—
Net margin %
-192.76
-1 686.53
-4 999.29
-33.7 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.08
8.08
1.67
1.8
2.38
9.79
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.29
0.03
0.02
0.01
0
0
Solvency ratios
Debt to assets ratio
0
—
—
0.71
0.36
1.02
Debt to equity ratio
0
—
—
-1.77
5.75
13.39
Long term debt to total assets ratio
0
—
—
0.71
0.36
1.02
Long term debt to total equity ratio
0
—
—
-1.77
5.75
13.39
Per share metrics
Operating cash flow per share
-1.86
-1.28
-6.47
-3.04
-2.41
-2.45
EBIT per share
-1.39
-1.32
-6.93
-3.67
-2.46
-2.52
EBITDA per share
-1.32
-1.31
-6.85
-3.64
-2.42
-2.49
Total debt per share
0
—
—
1.64
0.61
1.78
Cash per share
3.14
1.68
2.55
1.44
1.21
5.24
Net current asset value per share
3.23
1.71
3.23
1.7
1.26
5.57
Tangible book value per share
2.89
1.46
2.25
-0.93
0.11
1.14
Working capital per share
2.83
1.5
1.3
0.75
0.73
3.15
Book value per share
2.89
1.46
2.25
-0.93
0.11
1.14
Notícias
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
Elicio Therapeutics lança nova oferta de ações de até US$ 100 milhões
H.C. Wainwright eleva preço-alvo da Elicio Therapeutics para US$ 17
H.C. Wainwright raises Elicio Therapeutics price target to $17
Rodman & Renshaw inicia cobertura da Elicio Therapeutics com recomendação de compra
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
Elicio reports antigen spreading in 87% of evaluated cancer patients
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer
Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial
Elicio’s cancer therapy shows immune response across diverse HLA types